Jiasitang

Jiasitang Pharmaceutical Co., Ltd. is a subsidiary of China Everbright Group Co., Ltd. Jiasitang Pharmaceutical Co., Ltd. was established in 1997, listed on the Shenzhen Stock Exchange in 2010 (Jiasitang, 002462), and entered the Everbright system in 2018, becoming a major platform for Everbright's health business segment. In 2021, it ranked 11th among national pharmaceutical commercial enterprises. Under the strong leadership of the Party Committee of China Everbright Group, and guided by the strategy of building a globally competitive financial holding group, Jiasitang adheres to the vision of "Health and Happiness Accompany a Better Life," upholds the concept of "Innovation, Technology, and Transcendence," proactively responds to market changes, implements reform and innovation, supported by informatization, expands innovative businesses, and comprehensively enhances its competitive strength in drug sales, medical device sales, drug retail, pharmaceutical logistics, and innovative services, striving to become a leading comprehensive service provider of pharmaceutical commerce and medical rehabilitation. The company's main businesses include: sales to secondary and tertiary hospitals, sales to community medical centers, logistics distribution, and chain retail. The business scope includes: pharmaceuticals, biological products, medical devices, traditional Chinese medicine decoction pieces, etc.